Analysts Pitch Up to 1,000% Returns in Biotech Beyond Covid-19

(Bloomberg) -- Even a global pandemic hasn’t shaken optimism in one of the most volatile industries.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.